Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Initiating Treatment for Early Stage Myelofibrosis (MF) Disease
21:35
|
Download MP3
Related Videos
1:20
How do you treat patients with low platelet counts? - MPNUniversity.tv
0:55
What advice do you give to patients to manage itching? - MPNUniversity.tv
0:40
How do you treat patients with high platelet counts? - MPNUniversity
24:09
Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis
0:53
What should pharmacists know about ruxolitinib for patient education? - MPNUniversity.tv
1:54
How does therapy with ruxolitinib improve the quality of life? - MPNUniversity.tv
1:03
Are There Support Groups for Patients with MPNs? - MPNUniversity.tv
1:01
What are the frequent adverse drug reactions with ruxolitinib? - MPNUniversity.tv
1:02
What are the current combination strategies in the clinical setting? - MPNUniversity.tv
21:35
Initiating Treatment for Early Stage Myelofibrosis (MF) Disease
1:00
Can you combine other medications with ruxolitinib? - MPNUniversity.tv
1:06
What are the reasons people go off of ruxolitinib therapy? - MPNUniversity.tv
0:34
What was a limitation of the COMFORT II study? - MPNUniversity.tv
0:27
What happens if therapy with ruxolitinib has to be interrupted? - MPNUniversity.tv
19:49
What is the Current Standard of Care in Treating Polycythemia Vera (PV)?
1:00
What happens if therapy with ruxolitinib has to be interrupted? - MPNUniversity.tv
1:01
What is the typical duration of therapy with ruxolitinib? - MPNUniversity.tv
24:28
Loss of Response While Being Treated with a JAK Inhibitor
2:53
Sorafenib to Chemotherapy Improves the OS in Older Adults with FLT3-ITD Mutated AML
7:49
Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML
1:20 0:55 0:40 24:09 0:53 1:54 1:03 1:01 1:02 21:35 1:00 1:06 0:34 0:27 19:49 1:00 1:01 24:28 2:53 7:49
